Clinical Trials in San Diego

Showing 1781-1800 of 7,028 trials

SMART-CPT for PTSD/Concussion Implementation

NCT06995612

The clinical implementation trial will evaluate effectiveness and feasibility, acceptability, appropriateness, barriers, and facilitators of implementing SMART-CPT, a treatment targeting the two primary factors leading to poor outcomes following concussion, in Veterans. It will test effectiveness and broad implementation feasibility of SMART-CPT compared to standard Cognitive Processing Therapy (CPT).

PTSDConcussion, Mild

San Diego Veterans Healthcare System124 participantsStarted Dec 2024

San Diego, California, United States

COMPLETEDPhase 311 miles

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

NCT05275400

The reason for this study is to see if the study drug insulin efsitora alfa (LY3209590) is safe and effective in participants with Type 2 diabetes that have already been treated with basal insulin. The study consists of a 3-week screening/lead-in period, a 78-week treatment period and a 5-week safety follow-up period. The study will last up to 86 weeks.

Type 2 Diabetes

Eli Lilly and Company986 participantsStarted Mar 2022

Little Rock, Arkansas, United States • Concord, California, United States • Escondido, California, United States +124 more locations

SMART-CPT for PTSD/Concussion Implementation

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 2 Diabetes Currently Treated With Basal Insulin

Find Trials by Condition in San Diego

Randomized Therapy In Status Epilepticus

Research Study To See How Well An Eye Drop (SURF-200) Works, What Side Effects There Are, And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease

RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD

Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab

A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy

Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

MAGIC Ruxolitinib for aGVHD

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Early Feasibility Study of the RelayBranch Thoracic Stent-Graft System

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

Assessment of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis

Global Utilization And Registry Database for Improved heArt preservatioN

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults